Evidence map›Paper›PMID 38590655›Full record

ArticleFrontiers in oncology2024

Hong Song, Guoliang Mao, Nanlin Jiao, Jiajia Li, Wanwan Gao, Yinhua Liu, Linming Lu

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hong Song *Department of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Guoliang Mao *Department of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Nanlin JiaoDepartment of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Jiajia LiDepartment of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Wanwan GaoDepartment of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Yinhua LiuDepartment of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
Linming LuDepartment of Pathology, Wannan Medical College First Affiliated Hospital, Yijishan Hospital, Wuhu, Anhui, China.
First Affiliated Hospital of Wannan Medical College · CNWannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Angiomyolipoma with epithelial cysts (AMLEC) is an extremely rare subtype of kidney angiomyolipoma that contains epithelial-lined cysts. The most distinctive immunohistochemical feature of AMLEC is its immunoreactivity with melanocytic markers. AMLEC also has a distinct histological structure, which aids in its pathological diagnosis. To date 27 cases of AMLEC have been reported in 11 case series. However, the molecular biology underlying the pathogenesis of AMLEC remains unexplored. Case report: A 30-year-old female was diagnosed with AMLEC and underwent partial nephrectomy. Histologically, the cross-section of cystic tissue revealed a multilocular appearance, with some cysts containing thrombus-like material, and the wall thickness was approximately 0.2 ~ 0.3 cm. Additionally, the compact subepithelial cellular stroma showed strong and diffuse nuclear labeling for estrogen receptor, progesterone receptor, and CD10, as well as HMB45 and Melan A, which are markers of melanocytic differentiation. Furthermore, using a DNA targeted sequencing panel with next-generation sequencing, we identified a nonsense mutation in TSC Complex Subunit 2 ( Conclusion: To the best of our knowledge, this study represents the first analysis of genotype mutations in AMLEC, providing valuable insights for future clinical practice. These findings have significant potential in guiding the understanding and management of AMLEC, paving the way for further research and advancements in the field.

Indexed as

AMLECangiomyolipomacase reportPi3k-aktTSC2

Identifiers

PMID38590655
PMCPMC10999537
OpenAlexW4393157001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.